Dermatologic toxicities

Related by string. dermatologic toxicities * dermatologic : ERBITUX dermatologic toxicities . Doak Dermatologics subsidiary . Doak Dermatologics specializing / Toxicities : hematologic toxicities . non hematological toxicities . hematological toxicities * severe dermatologic toxicities . Dermatologic Toxicity Dermatologic toxicities . Severe dermatologic toxicities *

Related by context. Frequent words. (Click for all words.) 69 acneform rash 64 febrile neutropenia 64 lymphopenia 62 sensory neuropathy 62 laboratory abnormalities 62 leukopenia 61 Neutropenia 60 events AEs 60 events SAEs 60 relapsed refractory multiple myeloma 59 thrombocytopenia 59 pruritis 59 Lactic acidosis 59 diarrhea nausea vomiting 59 asthenia 58 patients receiving ERBITUX 58 hypomagnesemia 58 peripheral edema 58 myelosuppression 58 neutropenia 58 mucositis 57 infusion reactions 57 hypersensitivity reactions 57 invasive fungal infections 57 % CI #.#-#.# [007] 57 Arch Intern Med 57 chemotherapy induced neutropenia 56 Adverse events 56 stomatitis 56 Thrombocytopenia 56 aprepitant 56 unknown etiology 56 hypokalemia 56 Fibrillex TM 56 hypercalcemia 55 abdominal pain diarrhea 55 discontinuations due 55 venous thromboembolic events 55 relapsing multiple sclerosis 55 Peripheral neuropathy 55 Adverse reactions 55 bone marrow suppression 55 hepatotoxicity 55 TYSABRI treated 54 nasopharyngitis 54 AEs 54 TAXUS p value 54 concomitant medications 54 arthralgia 54 tumor lysis syndrome 54 hypocalcemia 54 % CI #.#-#.# [003] 54 renal toxicity 54 nausea diarrhea 54 Allergic rhinitis 54 COPD exacerbations 54 hypersensitivity reaction 54 renal insufficiency 54 REMICADE ® 54 elotuzumab 54 adrenal insufficiency 53 myalgia 53 hemolytic anemia 53 Secondary endpoints 53 discontinuations 53 C1 inhibitor deficiency 53 hypoglycemic events 53 cSSSI 53 BioMarin develops 53 neuropsychiatric symptoms 53 cardiac toxicity 53 pulmonary embolus 53 lactic acidosis 52 interstitial lung disease 52 radiation dermatitis 52 Hypoactive Sexual Desire Disorder 52 excessive menstrual bleeding 52 empyema 52 eczema psoriasis 52 musculoskeletal pain 52 hyperbilirubinemia 52 commercializes innovative biopharmaceuticals 52 angioedema 52 GEMZAR 52 fitball courses 51 Offering Pilates 51 Atopic Dermatitis 51 paroxysmal nocturnal hemoglobinuria 51 pulmonary disorders 51 thromboembolic events 51 Multiple sclerosis MS 51 limiting toxicity 51 anaphylactic reactions 51 aHUS 51 nonmalignant 51 SAEs 51 treatment emergent adverse 51 pneumonitis 51 serotonin syndrome 51 & s2 = 51 evaluable

Back to home page